Condition
Chronic Hepatitis B Virus (HBV) Infection
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT06650852Phase 2RecruitingPrimary
A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
NCT06906016RecruitingPrimary
New HBV Infection Biomarkers: Clinical Characterization and Impact on Management
NCT06874127RecruitingPrimary
Non-Invasive Model for Fibrosis Regression in HBV Patients
Showing all 3 trials